60 Degrees Pharmaceuticals to effect 1:4 reverse stock split effective Jan 20, 2026

60 DEGREES PHARMACEUTICALS, INC.

Reverse split at 1:4 ratio effective Jan 20, 2026 at 12:01 AM ET before market open.
Intended to regain compliance with Nasdaq minimum bid price requirement; symbol remains SXTP.
Shares outstanding reduce from ~5.15M to ~1.29M; fractional shares rounded up to whole share.
Approved by stockholders on Oct 8, 2025 and board on Dec 17, 2025; Delaware certificate filed.
All outstanding options, warrants, and equity plans adjusted proportionally.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

60 DEGREES PHARMACEUTICALS, INC.: Amended Certificate of Incorporation to effect a one-for-four reverse stock split (effective 2026-01-20).

Change: charter amendment
Effective: 2026-01-20

Exact text from the filing

On January 14, 2026, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware, which became effective at 12:01 a.m. Eastern Time on January 20, 2026.

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

60 DEGREES PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001213900-26-006179

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.